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Introduction: The accuracy of transvaginal ultrasound (TVS) for the identiﬁca-
tion of endometrial pathologies in postmenopausal, tamoxifen (TAM)-treated
breast cancer patients has been challenged, mainly due to a high false-positive
rate [1]. Therefore, sonohysterography (SIS) was introduced in order to improve
the diagnostic accuracy for such endometrial pathologies [1].
In this study, we used receiver operating characteristic (ROC) curve analysis to
detect the most accurate cut-oﬀ value in the intrauterine ﬁndings for the
diagnosis of endometrial pathologies, measured by SIS, in asymptomatic
postmenopausal, TAM-treated breast cancer patients with ultrasonographic
endometrial thicknesses of ‡ 8.0 mm.
Patients and methods: Overall, 85 patients were evaluated by SIS, operative
hysteroscopy or diagnostic hysteroscopy.
All patient records were evaluated for the mean ± standard deviation (SD) of
intrauterine mass diameter, as detected by SIS, for the endometrial histological
ﬁndings detected immediately thereafter, as well as for various clinical factors.
Logistic regression analysis and ROC curve were performed to identify the most
accurate cut-oﬀ value of mean intrauterine mass diameter, as measured by SIS,
for the diagnosis of endometrial pathologies.
Statistical analysis was performed using logistic regression and Chi-square
analyses. A value of P < 0.05 was considered statistically signiﬁcant.
Results: The duration of breast disease was 48.2 ± 41.9 months and the duration
of TAM treatment was 38.3 ± 30.7 months. Mean ultrasonographic endometrial
thickness was 14.56 ± 6.2 mm and mean intrauterine mass diameter, detected by
SIS, was 11.6 ± 10.4 mm.
The mean diameter of the intrauterine mass gradually increased as the
histological ﬁndings became more severe. False-negative and false-positive rates
of SIS were 2.4% and 8.2%, respectively.
Logistic regression analysis revealed low Odds Ratios for all parameters tested,
except for the diameter of intrauterine mass. With any additional millimetre of
diameter, the risk of development of new endometrial pathology was elevated by
1.37-fold [OddsRatio= 1.37, 95%Conﬁdence Interval (CI )= 1.21–1.56,P<0.001].
ROC curve analysis revealed 5 mm as the most accurate cut-oﬀ value for the
diagnosis of endometrial pathologies. With this cut-oﬀ value, SIS had a
sensitivity of 74.1%, speciﬁcity of 93.0%, positive predictive value of 88.3% and
negative predictive value of 84.2%.
Discussion: Our ﬁndings suggest that SIS is a highly speciﬁc diagnostic test for
postmenopausal, TAM-treated breast cancer patients. ROC curve revealed that
an intrauterine mass diameter of 5 mm was found to be the most accurate cut-oﬀ
value for the diagnosis of endometrial abnormalities.
Fong and colleagues [1] found SIS to be signiﬁcantly more speciﬁc, but not more
sensitive, than TVS for the detection of endometrial pathologies.
In our series, SIS had false-negative and false-positive rates of 2.4% and 8.2%,
respectively.
The mean diameter of intrauterine mass gradually increased with the increasing
severity of the histological ﬁndings. Polyps containing proliferative endometrium
had a diameter of 5.4 ± 5.1 mm, while those containing simple hyperplasia had a
diameter of 24.8 ± 13.8 mm. Moreover, the single polyp-containing malignancy
had a diameter of 43 mm.
Logistic regression analysis revealed that any additional millimetre in diameter
of the intrauterine mass, detected by SIS, increased the risk of developing new
endometrial pathology by 1.37-fold. This is a unique ﬁnding, which has not yet
been described.
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